These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17706556)

  • 1. The first steps towards gene therapy for Parkinson's disease.
    Svendsen C
    Lancet Neurol; 2007 Sep; 6(9):754-6. PubMed ID: 17706556
    [No Abstract]   [Full Text] [Related]  

  • 2. Adeno-associated viral vectors for Parkinson's disease.
    Muramatsu S; Wang L; Ikeguchi K; Fujimoto K; Nakano I; Okada T; Mizukami H; Hanazono Y; Kume A; Nakano I; Ozawa K
    Int Rev Neurobiol; 2003; 55():205-22. PubMed ID: 12968538
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards gene therapy for Parkinson's disease.
    Palfi S
    Lancet Neurol; 2008 May; 7(5):375-6. PubMed ID: 18387851
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkinson: the latest results of gene therapy].
    Nau JY
    Rev Med Suisse; 2014 Jan; 10(414):202-3. PubMed ID: 24624739
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus vectors for Parkinson's disease.
    Latchman DS
    Int Rev Neurobiol; 2003; 55():223-41. PubMed ID: 12968539
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy for Parkinson's disease: early data.
    Stoessl AJ
    Lancet; 2007 Jun; 369(9579):2056-8. PubMed ID: 17586286
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy trial for Parkinson's disease begins.
    Oransky I
    Lancet; 2003 Aug; 362(9385):712. PubMed ID: 12957111
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.
    Douglas MR
    Expert Rev Neurother; 2013 Jun; 13(6):695-705. PubMed ID: 23739006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for Parkinson's disease: a step closer?
    Stoessl AJ
    Lancet; 2014 Mar; 383(9923):1107-9. PubMed ID: 24412047
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral vectors, animal models and new therapies for Parkinson's disease.
    Schneider B; Zufferey R; Aebischer P
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S169-71. PubMed ID: 18585946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson disease: Another player in gene therapy for Parkinson disease.
    Kaplitt MG
    Nat Rev Neurol; 2010 Jan; 6(1):7-8. PubMed ID: 20057491
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
    Price RJ; Fisher DG; Suk JS; Hanes J; Ko HS; Kordower JH
    Mov Disord; 2019 Sep; 34(9):1279-1282. PubMed ID: 30908781
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo adenovirus-mediated gene transfer for Parkinson's disease.
    Horellou P; Bilang-Bleuel A; Mallet J
    Neurobiol Dis; 1997; 4(3-4):280-7. PubMed ID: 9361305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.
    Latchman DS
    J R Soc Med; 1999 Nov; 92(11):566-70. PubMed ID: 10703493
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glial cell line-derived neurotrophic factor for the rescue of dopaminergic neurons in Parkinson's disease].
    Honma Y; Kohsaka S
    No To Shinkei; 2003 Oct; 55(10):847-53. PubMed ID: 14635513
    [No Abstract]   [Full Text] [Related]  

  • 17. Trophic factor gene therapy for Parkinson's disease.
    Kordower JH; Bjorklund A
    Mov Disord; 2013 Jan; 28(1):96-109. PubMed ID: 23390096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for gene therapy in Parkinson's disease.
    Freese A; Stern M; Kaplitt MG; O'Connor WM; Abbey MV; O'Connor MJ; During MJ
    Mov Disord; 1996 Sep; 11(5):469-88. PubMed ID: 8866488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease.
    Bowers WJ; Howard DF; Federoff HJ
    Exp Neurol; 1997 Mar; 144(1):58-68. PubMed ID: 9126153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain.
    Cederfjäll E; Sahin G; Kirik D
    Neurobiol Dis; 2012 Nov; 48(2):222-7. PubMed ID: 22048069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.